Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 16, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Experts Explore the Key Success Factors for Portfolio Planning and LCM
SMi's Pharmaceutical Portfolio and Lifecycle Management conference returns to London in April for the 8th year running. 
x-small text small text medium text large text


    LONDON, ENGLAND, February 16, 2013 /24-7PressRelease/ -- SMi's Pharmaceutical Portfolio and Lifecycle Management conference returns to London in April for the 8th year running. The expert speakers will explore and debate the key success factors for portfolio planning and lifecycle management.

With R&D prices skyrocketing ever higher, and the drug development industry feeling the squeeze of the recession, there is an ever-increasing need to ensure a cost-effective and efficient portfolio. The planning and preparation for each drug portfolio must be optimised to provide maximum revenue for minimum expenditure.

Key issues for discussion this year will include how to design and produce products as cost-effectively as possible, modelling techniques to predict the lifecycle of a drug, paths to market, identifying and mitigating risks, and analysing a product's commercial prospects.

Among the speaker faculty this year are:

Kimber Hardy, Head of Valuation and Analysis, Merck Serono
Lucette Doessegger, Global Head of Licensing & Early Development, F. Hoffmann-La Roche
Michel Hamende, Director, Life Cycle Management, UCB Pharma
Tom Halliwell, Associate Director Programme Manager, Norgine
Richard Fazackerley, Director - Global Demand Chain Technology, Eisai
Gerhard Gross, Head of Drug Metabolism, Lundbeck
Vladimir Anisimov, Senior Strategic Biostatistics Director, Quintiles
Tim Harris, Former Senior Director, Established Products, EMAP, GSK
Mike Rea, Chief Executive Officer, IDEA Pharma UK

For more information visit http://www.smi-online.co.uk/goto/pharma-portfolio32.asp or contact Jonathan Collins on +44 (0)20 7827 6734 or email him at jcollins@smi-online.co.uk

SMi has a rich history of taking a great deal of time to prepare conferences sourcing key opinion leaders in their field. Content is designed deliberately to be topical, timely and relevant. Each conference is tailored to provide delegates with the opportunity to learn, engage and network with their industry peers and professionals. Each event has an average of 16 -18 speakers and all content is available to delegates online during and after the event.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Contact Information:
Cathy Bishop
SMi Group Limited

London, England
United Kingdom
Voice: 02078276734
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.